Orthofix Medical Inc (OFIX)

Currency in USD
12.37
+0.57(+4.83%)
Real-time Data·
Advertisement
OFIX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
11.9012.52
52 wk Range
8.8516.99
Key Statistics
Prev. Close
11.8
Open
11.97
Day's Range
11.9-12.52
52 wk Range
8.85-16.99
Volume
272.35K
Average Volume (3m)
427.65K
1-Year Change
14.8561%
Book Value / Share
10.84
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
OFIX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
15.50
Upside
+25.30%
Members' Sentiments
Bearish
Bullish
ProTips
Liquid assets exceed short term obligations

Orthofix Medical Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

3 Buy
2 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 15.50
(+25.30% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Canaccord
Buy18.00+45.63%-Maintain06/07/2026
Stifel
Buy15.00+21.36%18.00Maintain22/05/2026
TD Cowen
Hold12.00-2.91%14.00Maintain21/05/2026
Canaccord
Buy18.00+45.63%20.00Maintain21/05/2026
Canaccord
Buy20.00+61.81%-Maintain09/04/2026

Orthofix Medical Inc SWOT Analysis


Financial Resilience
Orthofix outperforms expectations in Q1 2025, showcasing strong operational efficiency despite strategic changes and market challenges
Strategic Repositioning
Delve into Orthofix's transition phase, including the M6 disc phase-out and new credit agreement, shaping its long-term growth trajectory
Product Innovation
Explore Orthofix's expanding portfolio, featuring early FDA approval for AccelStim 2.0 and new spine and ortho products, driving market position
Growth Projections
Analysts maintain a Market Perform outlook, with Orthofix targeting 6-7% top-line CAGR through 2027 and mid-teens adjusted EBITDA
Read full SWOT analysis

Orthofix Medical Inc Earnings Call Summary for Q1/2026

  • Orthofix Q1 2026 EPS of -$0.52 beat estimates by 14.75%; revenue hit $196.71M, up 3% YoY, exceeding forecasts by 1.77%
  • Stock surged 6.58% in pre-market to $12.80; strong cash position of $120.9M with non-GAAP adjusted EBITDA at $9.7M
  • Reaffirmed FY 2026 guidance of $850M-$860M in net sales, representing ~5.5% growth driven by spine and therapeutic solutions
  • CEO Calafiore highlighted strategic focus on innovation and distributor optimization; leadership restructuring in spine segment underway
  • Analysts maintain Buy consensus with price targets of $14-$20; key risks include geopolitical tensions and capital equipment timing variability
Last Updated: 05/05/2026, 14:30
Read Full Transcript

Earnings

Latest Release
05/05/2026
EPS / Forecast
-0.52 / -0.61
Revenue / Forecast
196.71M / 193.28M
EPS Revisions
Last 90 days

Compare OFIX to Peers and Sector

Metrics to compare
OFIX
Peers
Sector
Relationship
P/E Ratio
−8.3x−13.5x−0.4x
PEG Ratio
−0.13−0.850.00
Price/Book
1.1x4.6x2.6x
Price / LTM Sales
0.6x2.2x3.0x
Upside (Analyst Target)
35.6%26.3%56.0%
Fair Value Upside
Unlock−5.1%9.1%Unlock

Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulation devices that enhance bone fusion; designs, develops, and markets a portfolio of spine fixation implant products for use throughout the spinal column; and offers bone graft substitutes, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers in various forms with supporting graft delivery solutions to treat various spinal, orthopedic, and dental conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations; and 7D FLASH Navigation System, a navigation platform for spinal and cranial procedures. The Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market, including deformity correction, limb lengthening, complex fracture management, and limb preservation. This segment also designs, develops, and markets external and internal fixation limb reconstruction products that are coupled with enabling digital technologies to support the entire patient care continuum. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, healthcare providers, ambulatory surgery centers, and out-patient hospitals. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
9.26M22.92%109.32M
Other Institutional Investors
38.92M77.08%459.21M
Public Companies & Retail Investors
0.000.00%0.00
Total
48.18M100.00%568.54M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Engine Capital Management, LP11.32%4,575,67553,993
Juniper Investment Company, LLC10.99%4,442,54352,422

People Also Watch

307.34
SXI
+3.66%
12.95
MNRO
+5.71%
12.722
DSGN
+4.45%
28.65
HSTM
+2.18%
13.60
MPAA
+1.49%

FAQ

What Is the Orthofix (NASDAQ: OFIX) Share Price Today?

The Orthofix stock price today is 12.37 USD.

What Stock Exchange Does Orthofix (OFIX) Trade On?

Orthofix is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Orthofix?

The stock symbol (also called a 'ticker') for Orthofix is "OFIX."

What Is the Current Orthofix Market Capitalisation?

As of today, Orthofix (NASDAQ: OFIX) market cap is 500.02M USD.

What Is Orthofix's (OFIX) Earnings Per Share (TTM)?

The Orthofix EPS is currently -1.51 (Trailing Twelve Months).

When Is the Next Orthofix Earnings Date?

Orthofix's next earnings report will be released on 05/08/2026.

Is OFIX a Buy or Sell From a Technical Analyst Perspective?

Based on today's Orthofix moving averages and other technical indicators, the daily buy/sell signal for OFIX stock is Strong Buy.

How Many Times Has Orthofix Stock Split?

Orthofix has split 0 times. (See the OFIX stock split history page for full effective split date and price information.)

How Many Employees Does Orthofix Have?

Orthofix has 1605 employees, based on their latest Companies House report.

What is the current trading status of Orthofix (NASDAQ: OFIX)?

As of 03/08/2026, Orthofix (OFIX) is trading at a share price of 12.37 USD, with a previous close of 11.80 USD. The stock has fluctuated within a day range of 11.90 USD to 12.52 USD, while its 52-week range spans from 8.85 USD to 16.99 USD.

What Is Orthofix (OFIX) Price Target According to Analysts?

The average 12-month price target for Orthofix is 15.50 USD, with a high estimate of 18 USD and a low estimate of 12 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +25.30% Upside potential.

What Is the OFIX Premarket Price?

OFIX's last pre-market stock price is 11.63 USD. The pre-market share volume is 110.00, and the stock has decreased by -0.17, or -1.44%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.